Table 4.
Botx-A (n=20) | Placebo (n=18) | |
---|---|---|
Adverse events (total) | 9 (45.0%) | 7 (38.8%) |
Pain in injected points | 6 (30.0%) | 2 (11.1%) |
Burning sensation in injected points | 4 (20.0%) | 2 (11.1%) |
Headache after injection | 2 (10.0%) | 1 (5.5%) |
Botx-A (n=20) | Placebo (n=18) | |
---|---|---|
Adverse events (total) | 9 (45.0%) | 7 (38.8%) |
Pain in injected points | 6 (30.0%) | 2 (11.1%) |
Burning sensation in injected points | 4 (20.0%) | 2 (11.1%) |
Headache after injection | 2 (10.0%) | 1 (5.5%) |